A. Martens

发表

Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients.

D. Schadendorf, B. Schilling, D. Mallardo, 2017, European journal of cancer.

Characterization of Oxygen Levels in an Uninfected and Infected Human Blood-Cerebrospinal-Fluid-Barrier Model

H. Schroten, M. von Köckritz-Blickwede, A. Martens, 2022, Cells.

Effects of nabumetone compared with naproxen on platelet aggregation in patients with rheumatoid arthritis

A. Martens, E. Knijff-Dutmer, M. A. F. J. Laar, 1999, Annals of the rheumatic diseases.

ects of nabumetone compared with naproxen on platelet aggregation in patients with rheumatoid arthritis

A. Martens, Ellen A J Knij, -. Dutmer, 1999 .

E ects of nabumetone compared with naproxen on platelet aggregation in patients with rheumatoid arthritis

A. Martens, Ellen A J Knij, -. Dutmer, 1999 .

Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma—safety and efficacy in a phase II study

H. Lipp, C. Garbe, B. Klumpp, 2017, Cancer Immunology, Immunotherapy.

Survival of Streptococcus suis in Porcine Blood Is Limited by the Antibody- and Complement-Dependent Oxidative Burst Response of Granulocytes

W. Schrödl, N. Schütze, M. von Köckritz-Blickwede, 2019, Infection and Immunity.

Intralesional Treatment of Stage III Metastatic Melanoma Patients with L19–IL2 Results in Sustained Clinical and Systemic Immunologic Responses

J. Becker, C. Garbe, G. Pawelec, 2014, Cancer Immunology Research.

Low-dose regimen of interleukin-2 for metastatic renal carcinoma

N. Mulder, A. Martens, P. Willemse, 1990, The Lancet.

Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab

D. Schadendorf, B. Schilling, G. Madonna, 2016, Clinical Cancer Research.

A clinical and biological perspective of human myeloid-derived suppressor cells in cancer

G. Pawelec, A. Martens, C. Shipp, 2016, Cellular and Molecular Life Sciences.

Monocytic myeloid-derived suppressor cells in advanced melanoma patients

C. Garbe, G. Pawelec, B. Weide, 2014, Oncoimmunology.

In vivo oxygen measurement in cerebrospinal fluid of pigs to determine physiologic and pathophysiologic oxygen values during CNS infections

A. Beineke, M. von Köckritz-Blickwede, A. Martens, 2021, BMC Neuroscience.

Tumor Necrosis Factor-α, Interleukin-1β, and Interleukin-6 Plasma Levels in Neonatal Sepsis

W. Fetter, E. Bont, A. Martens, 1993, Pediatric Research.

The prognostic impact of specific CD4 T-cell responses is critically dependent on the target antigen in melanoma

C. Garbe, G. Pawelec, B. Weide, 2015, Oncoimmunology.

Telomerase Does Not Improve DNA Repair in Mitochondria upon Stress but Increases MnSOD Protein under Serum-Free Conditions

G. Saretzki, A. Martens, B. Schmid, 2019, International journal of molecular sciences.

Neutrophil function capacity to express CD10 is decreased in patients with septic shock.

A. Martens, A. Woittiez, L. D. de Leij, 1999, Critical care medicine.

Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response.

L. de Leij, T. The, N. Mulder, 1993, British Journal of Cancer.

Phase I/II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer.

L. de Leij, J. Buter, D. Sleijfer, 1993, European journal of cancer.

Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 plasma levels in neonatal sepsis.

W. Fetter, A. Martens, A. Okken, 1993, Pediatric research.

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

D. Schadendorf, B. Schilling, P. Ascierto, 2016, Clinical Cancer Research.

Expansion and Determination of Antigen-Reactive T Cells by Flow Cytometry.

G. Pawelec, A. Martens, C. Shipp, 2019, Methods in molecular biology.

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

C. Berking, D. Schadendorf, B. Schilling, 2016, Clinical Cancer Research.

Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma : Comparison with Regulatory T Cells and NY-ESO-1-or MelanA – Speci fi c T Cells

D. Schadendorf, B. Schilling, C. Garbe, 2014 .

Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A–Specific T Cells

D. Schadendorf, B. Schilling, C. Garbe, 2013, Clinical Cancer Research.

NY-ESO-1- or Melan-A-specific T cells melanoma patients: comparison with regulatory T cells and Myeloid-derived suppressor cells predict survival of advanced

B. Weide, A. Martens, H. Zelba, 2013 .

Myeloid-derived suppressor cells predict survival of advanced melanoma patients : comparison with regulatory T cells and NY-ESO-1-or MelanA-specific T cells

D. Schadendorf, C. Garbe, G. Pawelec, 2013 .

Establishing High Dimensional Immune Signatures from Peripheral Blood via Mass Cytometry in a Discovery Cohort of Stage IV Melanoma Patients

C. Garbe, G. Pawelec, E. Newell, 2017, The Journal of Immunology.

First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis

D. Schadendorf, B. Schilling, A. Gesierich, 2019, Cancer Immunology, Immunotherapy.

Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma.

J. Utikal, C. Berking, A. Gesierich, 2017, European journal of cancer.

High GDF-15 Serum Levels Independently Correlate with Poorer Overall Survival of Patients with Tumor-Free Stage III and Unresectable Stage IV Melanoma.

C. Garbe, J. Wischhusen, M. Mittelbronn, 2016, The Journal of investigative dermatology.

Ocular adverse events associated with immune checkpoint inhibitors, a scoping review

I. Casteels, S. Aspeslagh, A. Martens, 2023, Journal of Ophthalmic Inflammation and Infection.

Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab.

D. Schadendorf, B. Schilling, P. Ascierto, 2016, European journal of cancer.

Circulating CD4+ T Cells That Produce IL4 or IL17 When Stimulated by Melan-A but Not by NY-ESO-1 Have Negative Impacts on Survival of Patients with Stage IV Melanoma

D. Schadendorf, C. Garbe, G. Pawelec, 2014, Clinical Cancer Research.

Biology of Human Tumors Circulating CD 4 þ T Cells That Produce IL 4 or IL 17 When Stimulated by MelanA but Not by NY-ESO-1 Have Negative Impacts on Survival of Patients with Stage IV Melanoma

D. Schadendorf, G. Pawelec, M. Maio, 2014 .

Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma

C. Garbe, G. Pawelec, M. Claassen, 2023, Journal for ImmunoTherapy of Cancer.

Diagnostic value of plasma levels of tumor necrosis factor α (TNFα) and interleukin‐6 (IL‐6) in newborns with sepsis

E. Bont, A. Martens, A. Okken, 1994, Acta paediatrica.